OBJECTIVE: Rheumatoid arthritis (RA) is a progressive disease including four stages, where gut microbiome is associated with pathogenesis. We aimed to investigate stage-specific roles of microbial dysbiosis and metabolic disorders in RA.
Investigation of different proteins that play role in the formation of boundary between DK1622 and the incompatible mutant strain via proteomics approach.
